As of the most recent data (June 2026), ACHFF shows a current cash of $2.9K. That compares with $170K in the prior-year period — down 98.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACHFF's current cash is now $2.9K (was $170K) — a 98.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Arch Biopartners is outperforming or lagging.

Tracking ACHFF's current cash over time shows whether Arch Biopartners is scaling, shrinking, or reshaping that part of the business. The current reading is $2.9K That compares with $170K in the prior-year period — down 98.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Arch Biopartners's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $2.9K) with ownership activity and broader fundamentals.

Arch Biopartners's current cash is $2.9K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.